Community clinics test smarter ways to spot cancer genes

NCT ID NCT05664867

Recruiting now Knowledge-focused Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two methods of offering cancer genetic testing to patients in community health centers. One method lets primary care doctors order tests directly, while the other uses a specialist model with extra support. Researchers will track how many patients get tested and how long it takes, and interview patients and staff to learn what works best.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show the best way to offer cancer genetic testing in community clinics, helping more at-risk people get tested.
What could go wrong: This is a small, early-stage study focused on comparing service models, not testing a new treatment. Results may not apply to other clinics or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEREDITARY CANCER SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary neoplastic syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEREDITARY CANCER SYNDROME

Contacts and locations

Locations

University of Illinois Cancer Center
RECRUITING

Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.